Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Nasopharyngeal Carcinoma 21Prostatic Neoplasms 8Breast Neoplasms 7Head and Neck Neoplasms 6Esophageal Squamous Cell Carcinoma 6Esophageal Neoplasms 6Rectal Neoplasms 4Radiation Injuries 4Carcinoma, Squamous Cell 4Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Nasopharyngeal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Recurrence 2Lung Neoplasms 2Vulvar Neoplasms 1Thyroid Neoplasms 1Sinonasal undifferentiated carcinoma 1Radiation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Obesity 1Neurotoxicity Syndromes 1Neoplasms 1

Interventions

Paclitaxel 35Carboplatin 35Bevacizumab 14olaparib 13niraparib 11apatinib 11Gemcitabine 10liposomal doxorubicin 9Hyperthermic Intraperitoneal Chemotherapy 9Cisplatin 9pembrolizumab 8Cyclophosphamide 8fludarabine 7Etoposide 7Topotecan 6fluzoparib 5Surveys and Questionnaires 5Drug Therapy 5Albumin-Bound Paclitaxel 5anlotinib 4Immunohistochemistry 4Ifosfamide 4Doxorubicin 4Docetaxel 4Cytoreduction Surgical Procedures 4Taxes 3Surgical Procedures, Operative 3Poly(ADP-ribose) Polymerase Inhibitors 3Neoadjuvant Therapy 3Laparoscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Ovarian Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT05059782 2021-09-28

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Xi'an Jiaotong University

Phase NA Unknown
150 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡